COVID-19 treatments

The study looks at hospitalized patients predominantly in the US along with Spain, China, and South Korea. The roughly 300,000 patients received a combination of 3455 different repurposed and adjunctive drugs.
This will mark the fourth article in a little over a week on ivermectin on our website, and we are not alone.
Last winter, extending into the early spring, the treatment for COVID-19 was at best ill-defined. All of our treatment protocols seemed ineffective, and healthcare teams tried everything under the sun to save lives.
“It’s an easy conclusion, often appropriate. Given a choice, most people gravitate toward the natural over the artificial.